![Jim Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Connolly
Direttore/Membro del Consiglio presso
VALNEVA SE
Patrimonio netto: 51 563 $ in data 30/06/2026
Profilo
James Edward Connolly currently works at Covenant House, Inc., as Director, Valneva SE, as Independent Director from 2023, and International AIDS Vaccine Initiative, Inc., as Director from 2011.
Mr. Connolly also formerly worked at Tivorsan Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2015 to 2020, Emergent Travel Health, Inc., as Director from 2014 to 2018, Pivotal Therapeutics, Inc., as Director in 2014, Ambulatus Robotics, Inc., as Director from 2020 to 2021, Aeras Global TB Vaccine Foundation, as Director in 2013, Vaxess Technologies, Inc., as Director from 2013 to 2019, Wyeth Pharmaceuticals LLC, as Executive Vice President & General Manager, and Wyeth Canada ULC, as President.
Mr. Connolly received his undergraduate degree from Washington University in St. Louis.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VALNEVA SE 0,01% | 31/12/2025 | 20.000 ( 0,01% ) | 51 563 $ | 30/06/2026 |
Posizioni attive di Jim Connolly
| Società | Posizione | Inizio |
|---|---|---|
| VALNEVA SE | Direttore/Membro del Consiglio | 24/06/2022 |
Covenant House, Inc. | Direttore/Membro del Consiglio | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Direttore/Membro del Consiglio | 01/01/2011 |
Precedenti posizioni note di Jim Connolly
| Società | Posizione | Fine |
|---|---|---|
Ambulatus Robotics, Inc. | Direttore/Membro del Consiglio | 02/01/2021 |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Amministratore Delegato | 01/01/2020 |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Direttore/Membro del Consiglio | 01/01/2019 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Direttore/Membro del Consiglio | 01/10/2018 |
| PIVOTAL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 23/04/2014 |
Formazione di Jim Connolly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pivotal Therapeutics, Inc.
 Pivotal Therapeutics, Inc. Financial ConglomeratesFinance Operates as a specialty pharmaceutical company | Finance |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Health Technology |
Wyeth Canada ULC
 Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Covenant House, Inc. | |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Tivorsan Pharmaceuticals, Inc.
Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
Ambulatus Robotics, Inc. |
